Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood

for
Pediatric Cancer
Location: Montreal
Sponsor: St. Justine's Hospital

Sex: All

Age: 0 - 21

Code: NCT02242552

Recruiting

Predicting Chronic Pain Following Breast Surgery

for
Chronic Pain, Opioid Use, Breast Pain, Breast Cancer
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT04967352

Recruiting

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

for
Metastatic Malignant Solid Neoplasm, Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05371132

Phase 1, Recruiting

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

for
Neoplasms, Plasma Cell, Neoplasms by Histologic Type, Neoplasms,
Location: Atlanta GA
Sponsor: OriCell Therapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06271252

Phase 1, Recruiting

A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Providence RI, Houston TX
Sponsor: TYK Medicines, Inc

Sex: All

Age: 18+

Code: NCT05769075

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of ICP-192 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors, Urothelial Carcinoma, Cholangiocarcinoma
Location: Lake Success NY, Bronx NY, Columbus OH, Minneapolis MN,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18+

Code: NCT04565275

Phase 1, Phase 2, Recruiting

Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers

for
Cervical Carcinoma, Fallopian Tube Carcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 18+

Code: NCT06492070

Phase 2, Recruiting

A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer

for
Cancer
Location: Irvine CA
Sponsor: University of California, Irvine

Sex: Male

Age: 18 - 39

Code: NCT06338475

Recruiting

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for
Solid Tumor
Location: Providence RI, New York NY, Hackensack NJ, Newark DE,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT05584670

Phase 1, Phase 2, Recruiting

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

for
Metastatic Triple-Negative Breast Carcinoma, Breast Cancer
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: Female

Age: 18+

Code: NCT06008275

Early Phase 1, Recruiting

Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

for
Breast Cancer, Axillary Lymph Nodes
Location: Houston TX
Sponsor: Endomagnetics Ltd.

Sex: All

Age: 18+

Code: NCT03796559

Recruiting

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

for
Solid Tumors
Location: Philadelphia PA, Gainesville FL, Houston TX
Sponsor: Shionogi

Sex: All

Age: 18+

Code: NCT05101070

Phase 1, Phase 2, Recruiting

YL-13027 in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: Houston TX
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.

Sex: All

Age: 18+

Code: NCT05228600

Phase 1, Recruiting

Umbrella Study for Single Patient Treatments in Oncology

for
Advanced Cancer, Rare Diseases
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06285500

Recruiting

Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy

for
Hematologic Malignancy, Solid Tumor, Sickle Cell Disease,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 8+

Code: NCT06689800

Recruiting

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Philadelphia PA, Kissimmee FL, Gainesville FL,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06352359

Phase 1, Recruiting

Prehab for Lung and Esophageal Cancer

for
Neoplasm of Lung, Neoplasms, Exercise, Surgery
Location: Halifax
Sponsor: Nova Scotia Health Authority

Sex: All

Age: 18+

Code: NCT06354959

Recruiting

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

for
Breast Carcinoma, Breast Ductal Carcinoma in Situ
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: Female

Age: 18+

Code: NCT06350500

Recruiting

Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast Surgery

for
Breast Cancer
Location: Toronto
Sponsor: University of Toronto

Sex: Female

Age: 18 - 65

Code: NCT04616300

Recruiting

Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study

for
HER2-positive Breast Cancer, LMD
Location: Ottawa, Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT06016387

Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial